Alonso Soto

Dr. Alonso Soto

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2006 in BMJ
Verified
Journal Article
Closed access
PDF file
FCFrançois Chappuis
François Chappuis
SRSuman Rijal
Suman Rijal
ASAlonso Soto
Alonso Soto
JMJoris Menten
Joris Menten
MBMarleen Boelaert
Marleen Boelaert
Objective To compare the performance of the direct agglutination test and rK39 dipstick for the diagnosis of visceral leishmaniasis. Data sources Medline, citation tracking, January 1986 to December 2004. Selection criteria Original studies evaluating the direct agglutination test or the rK39 dipstick with clinical visceral leishmaniasis as target condition; adequate reference classification; and absolute numbers of true positive, true negative, false positive, and false negative observations available or derivable from the data presented. Results 30 studies evaluating the direct agglutination test and 13 studies evaluating the rK39 dipstick met the inclusion criteria. The combined sensitivity estimates of the direct agglutination test and the rK39 dipstick were 94.8% (95% confidence interval 92.7% to 96.4%) and 93.9% (87.7% to 97.1%), respectively. Sensitivity seemed higher and more homogenous in the studies carried out in South Asia. Specificity estimates were influenced by the type of controls. In phase III studies carried out on patients with clinically suspected disease, the estimated specificity of the direct agglutination test was 85.9% (72.3% to 93.4%) and of the rK39 dipstick was 90.6% (66.8% to 97.9%). Conclusion The diagnostic performance of the direct agglutination test and the rK39 dipstick for visceral leishmaniasis is good to excellent and seem comparable.

12 January 2021 in Revista de la Facultad de Medicina Humana
Verified
Journal Article
Open access
PDF file
AVAleksandar Cvetković Vega
Aleksandar Cvetković Vega
JMJorge L. Maguiña
Jorge L. Maguiña
ASAlonso Soto
Alonso Soto
JLJaime Lama-Valdivia
Jaime Lama-Valdivia
LLLucy E. Correa López
Lucy E. Correa López
Cross-sectional studies are epidemiological design which can be considered as descriptive or analytical designs depending on the general objective. This is a quickly and economical design and allows to calculate the prevalence of a condition. Also, the relationship of temporality between the exposition and the outcome is being measured simultaneously on a unique period, not being possible to identify a directionality in the temporality. When there is an analytic objective, the association measure used is the Prevalence Ratio (PR), specially when the prevalence of the outcome is more or equal to 10% or the Odds Ratio (OR) when that prevalence is lower. To quantify this association different regression models like Binomial log or Poisson log can be used, including generalized lineal models. If the association measure is OR, the most common used model is the multiple logistic regression. Los estudios observacionales transversales pueden ser de tipo descriptivos o también analíticos dependiendo del objetivo general. Este diseño es rápido, económico y permite el cálculo directo de la prevalencia de una condición. Además, la relación de temporalidad entre la exposición y el efecto son medidas de forma simultánea en un único período, no siendo posible identificar una direccionalidad en la temporalidad. Cuando estos estudios persiguen un objetivo general analítico, la medida de asociación es la Razón de Prevalencias (RP), especialmente cuando la prevalencia del efecto es mayor o igual a 10% o el Odds Ratio (OR) cuando la prevalencia es baja. Para cuantificar esta asociación pueden utilizarse diferentes modelos de regresión como el binomial log o Poisson log, incluyendo los modelos lineales generalizados. Cuando la medida de asociación a utilizar es el OR, el modelo más comúnmente empleado es la regresión logística múltiple.

27 June 2003 in Molecular Biology and Evolution
Verified
Journal Article
Closed access
PDF file
SFSilvia Fuselli
Silvia Fuselli
ETEduardo Tarazona-Santos
Eduardo Tarazona-Santos
IDIsabelle Dupanloup
Isabelle Dupanloup
ASAlonso Soto
Alonso Soto
DLDonata Luiselli
Donata Luiselli
DPDavide Pettener
Davide Pettener
We analyzed mtDNA sequence variation in 590 individuals from 18 south Amerindian populations. The spatial pattern of mtDNA diversity in these populations fits well the model proposed on the basis of Y-chromosome data. We found evidence of a differential action of genetic drift and gene flow in western and eastern populations, which has led to genetic divergence in the latter but not in the former. Although it is not possible to identify a pattern of genetic variation common to all South America, when western and eastern populations are analyzed separately, the mtDNA diversity in both regions fits the isolation-by-distance model, suggesting independent evolutionary dynamics. Maximum-likelihood estimates of divergence times between central and south Amerindian populations fall between 13,000 and 19,000 years, which is consistent with a Pleistocenic peopling of South America. Moreover, comparison of among-population variability of mtDNA and Y-chromosome DNA seems to indicate that South America is the only continent where the levels of differentiation are similar for maternal and paternal lineages.

1 December 2013 in International Journal of Infectious Diseases
Verified
Journal Article
Closed access
LSLely Solari
Lely Solari
ASAlonso Soto
Alonso Soto
JAJuan Carlos Agapito
Juan Carlos Agapito
VAVilma Acurio
Vilma Acurio
DVDante Vargas
Dante Vargas
PSPatrick van der Stuyft
Patrick van der Stuyft

2 March 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ASAlonso Soto
Alonso Soto
DQDante M. Quiñones-Laveriano
Dante M. Quiñones-Laveriano
JAJohan Azanero-Haro
Johan Azanero-Haro
RCRafael Chumpitaz
Rafael Chumpitaz
JCJosé Claros
José Claros
AAAndres Alcantara
Andres Alcantara
Objectives: To determine the risk factors for in-hospital mortality in patients with COVID-19 from a Peruvian national hospital. Methods: Retrospective cohort study of medical records of patients with COVID-19 hospitalized at Hospital Nacional Hipólito Unanue (HNHU) during the months of April to August 2020. The dependent variable was in-hospital mortality. Independent variables included sociodemographic and clinical characteristics, physical examination findings, oxygen saturation (SaO2) at admission, treatment received during hospitalization and laboratory results at admission. A Cox regression model was used to evaluate the crude and adjusted hazard ratios for associated factors. Results: We included 1418 patients. Median age was 58 years (IQR 47–68 years) and 944 (66.6%) were male. The median length of hospitalization was 7 (4–13) days, and the mortality rate was 46%. The most frequent comorbidities were type 2 diabetes mellitus, hypertension, and obesity. In the adjusted analysis, mortality was associated with age (HR 1.02; 95%CI 1.02–1.03), history of surgery (HR 1.89; 95%CI 1.31–2.74), lower oxygen saturation at admission (HR 4.08; CI95% 2.72–8.05 for SaO294%), the presence of poor general condition (HR 1.81; 95% CI 1.29–2.53), altered state of consciousness (HR 1.58; 95%CI 1.18–2.11) and leukocyte levels (HR 1.01; 95%CI 1.00–1. 02). Treatment with ivermectin (HR 1.44; 95%CI 1.18–1.76) and azithromycin (HR 1.25; 95%CI 1.03–1.52) were associated with higher mortality. Treatment with corticosteroids at low to moderate doses was associated with lower mortality (HR 0.56 95%CI 0. 37–0. 86) in comparison to no steroid use. Conclusion: A high mortality was found in our cohort. Low oxygen saturation at admission, age, and the presence of hematological and biochemical alterations were associated with higher mortality. The use of hydroxychloroquine, ivermectin or azithromycin was not useful and was probably associated with unfavorable outcomes. The use of corticosteroids at moderate doses was associated with lower mortality.

1 April 2008 in The Brazilian Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
ASAlonso Soto
Alonso Soto
LSLely Solari
Lely Solari
JAJuan Agapito
Juan Agapito
CACarlos Acuna-Villaorduna
Carlos Acuna-Villaorduna
MLMarie-Laurence Lambert
Marie-Laurence Lambert
PSPatrick Van der Stuyft
Patrick Van der Stuyft
This study developed a clinical score based on clinical and radiographic data for the diagnosis of smear-negative pulmonary tuberculosis (SNPT). SNPT was defined as a positive culture in Ogawa in a patient with two negative sputum smears. Data from patients admitted to the emergency ward with respiratory symptoms and negative acid-fast bacilli (AFB) smears was analyzed by means of logistic regression to develop the predictive score.Two hundred and sixty two patients were included. Twenty patients had SNPT. The variables included in the final model were hemoptysis, weight loss, age > 45 years old, productive cough, upper-lobe infiltrate, and miliary infiltrate. With those, a score was constructed. The score values ranged from -2 to 6. The area under the curve for the ROC curve was 0.83 (95% CI 0.74-0.90). A score of value 0 or less was associated with a sensitivity of 93% and a score of more than 4 points was associated with a specificity of 92% for SNPT. Fifty-two point twenty-nine percent of patients had scores of less than one or more than four, what provided strong evidence against and in favor, respectively, for the diagnosis of SNPT. The score developed is a cheap and useful clinical tool for the diagnosis of SNPT and can be used to help therapeutic decisions in patients with suspicion of having SNPT